id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2018-N-2434-0002,FDA,FDA-2018-N-2434,"Agency Information Collection Activities; Submission for Office of
Management and Budget Review; Comment Request; Guidance for
Industry on Formal Meetings With Sponsors and Applicants for
Prescription Drug User Fee Act Products",Notice,30 Day Proposed Information Collection,2018-10-22T04:00:00Z,2018,10,2018-10-22T04:00:00Z,2018-11-22T04:59:59Z,2018-10-22T14:48:23Z,2018-22954,0,0,0900006483837856
FDA-2018-N-2434-0001,FDA,FDA-2018-N-2434,Agency Information Collection Activities; Proposed Collection; Comment Request; Guidance for Industry on Formal Meetings With Sponsors and Applicants for Prescription Drug User Fee Act Products,Notice,60 Day Proposed Information Collection,2018-07-11T04:00:00Z,2018,7,2018-07-11T04:00:00Z,2018-09-11T03:59:59Z,2018-07-11T13:25:33Z,2018-14800,0,0,09000064834d018c